Disclosures for "Plasma Glial Fibrillary Acidic Protein (GFAP) as a Biomarker of Acute Focal Brain Injury"
-
Dr. Saez Calveras has nothing to disclose.
-
Dr. Asturias has nothing to disclose.
-
Dr. Yu has nothing to disclose.
-
Dr. Stopschinski has nothing to disclose.
-
Dr. Vaquer-Alicea has nothing to disclose.
-
The institution of Dr. O'Suilleabhain has received research support from ONO pharmaceutical. The institution of Dr. O'Suilleabhain has received research support from Integrated Research Laboratories.
-
The institution of Dr. Diamond has received research support from NIH. Dr. Diamond has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Shah has received personal compensation in the range of $0-$499 for serving as a Consultant for Insightec.